BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 15955740)

  • 21. A uniquely human consequence of domain-specific functional adaptation in a sialic acid-binding receptor.
    Sonnenburg JL; Altheide TK; Varki A
    Glycobiology; 2004 Apr; 14(4):339-46. PubMed ID: 14693915
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sialic acid binding immunoglobulin-like lectins may regulate innate immune responses by modulating the life span of granulocytes.
    von Gunten S; Simon HU
    FASEB J; 2006 Apr; 20(6):601-5. PubMed ID: 16581967
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunomodulatory activity of extracellular Hsp70 mediated via paired receptors Siglec-5 and Siglec-14.
    Fong JJ; Sreedhara K; Deng L; Varki NM; Angata T; Liu Q; Nizet V; Varki A
    EMBO J; 2015 Nov; 34(22):2775-88. PubMed ID: 26459514
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Siglecs--the major subfamily of I-type lectins.
    Varki A; Angata T
    Glycobiology; 2006 Jan; 16(1):1R-27R. PubMed ID: 16014749
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Siglecs as targets for therapy in immune-cell-mediated disease.
    O'Reilly MK; Paulson JC
    Trends Pharmacol Sci; 2009 May; 30(5):240-8. PubMed ID: 19359050
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Siglecs, sialic acids and innate immunity.
    Crocker PR; Varki A
    Trends Immunol; 2001 Jun; 22(6):337-42. PubMed ID: 11377294
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gene conversions are frequent but not under positive selection in the Siglec gene families of primates.
    Zid M; Drouin G
    Genome; 2014 Jun; 57(6):317-25. PubMed ID: 25166301
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human-specific expression of Siglec-6 in the placenta.
    Brinkman-Van der Linden EC; Hurtado-Ziola N; Hayakawa T; Wiggleton L; Benirschke K; Varki A; Varki N
    Glycobiology; 2007 Sep; 17(9):922-31. PubMed ID: 17580316
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Probing the cis interactions of the inhibitory receptor Siglec-7 with alpha2,8-disialylated ligands on natural killer cells and other leukocytes using glycan-specific antibodies and by analysis of alpha2,8-sialyltransferase gene expression.
    Avril T; North SJ; Haslam SM; Willison HJ; Crocker PR
    J Leukoc Biol; 2006 Oct; 80(4):787-96. PubMed ID: 16857734
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of the CD33-related siglec family reveals that Siglec-9 is an endocytic receptor expressed on subsets of acute myeloid leukemia cells and absent from normal hematopoietic progenitors.
    Biedermann B; Gil D; Bowen DT; Crocker PR
    Leuk Res; 2007 Feb; 31(2):211-20. PubMed ID: 16828866
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cloning and characterization of a novel mouse Siglec, mSiglec-F: differential evolution of the mouse and human (CD33) Siglec-3-related gene clusters.
    Angata T; Hingorani R; Varki NM; Varki A
    J Biol Chem; 2001 Nov; 276(48):45128-36. PubMed ID: 11579105
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Viewing Siglecs through the lens of tumor immunology.
    Fraschilla I; Pillai S
    Immunol Rev; 2017 Mar; 276(1):178-191. PubMed ID: 28258691
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ITIM-dependent endocytosis of CD33-related Siglecs: role of intracellular domain, tyrosine phosphorylation, and the tyrosine phosphatases, Shp1 and Shp2.
    Walter RB; Raden BW; Zeng R; Häusermann P; Bernstein ID; Cooper JA
    J Leukoc Biol; 2008 Jan; 83(1):200-11. PubMed ID: 17947393
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Loss of N-glycolylneuraminic acid in human evolution. Implications for sialic acid recognition by siglecs.
    Brinkman-Van der Linden EC; Sjoberg ER; Juneja LR; Crocker PR; Varki N; Varki A
    J Biol Chem; 2000 Mar; 275(12):8633-40. PubMed ID: 10722703
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular diversity and evolution of the Siglec family of cell-surface lectins.
    Angata T
    Mol Divers; 2006 Nov; 10(4):555-66. PubMed ID: 16972014
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Functions and molecular evolution of Siglecs, a family of sialic acid receptor proteins].
    Angata T
    Tanpakushitsu Kakusan Koso; 2008 May; 53(6):733-8. PubMed ID: 18453149
    [No Abstract]   [Full Text] [Related]  

  • 37. Cloning and characterization of human Siglec-11. A recently evolved signaling molecule that can interact with SHP-1 and SHP-2 and is expressed by tissue macrophages, including brain microglia.
    Angata T; Kerr SC; Greaves DR; Varki NM; Crocker PR; Varki A
    J Biol Chem; 2002 Jul; 277(27):24466-74. PubMed ID: 11986327
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Siglecs: A journey through the evolution of sialic acid-binding immunoglobulin-type lectins.
    Bornhöfft KF; Goldammer T; Rebl A; Galuska SP
    Dev Comp Immunol; 2018 Sep; 86():219-231. PubMed ID: 29751010
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evolution of sialic acid-binding proteins: molecular cloning and expression of fish siglec-4.
    Lehmann F; Gäthje H; Kelm S; Dietz F
    Glycobiology; 2004 Nov; 14(11):959-68. PubMed ID: 15229193
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Probing sialic acid binding Ig-like lectins (siglecs) with sulfated oligosaccharides.
    Rapoport EM; Pazynina GV; Sablina MA; Crocker PR; Bovin NV
    Biochemistry (Mosc); 2006 May; 71(5):496-504. PubMed ID: 16732727
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.